Translational Bioinformatics and Experimental Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed)
This grant funds research aimed at advancing drug repositioning and combination therapy development for Alzheimer's disease and related dementias.
About this program
The grant focuses on translational bioinformatics and experimental approaches to enhance the understanding and treatment of Alzheimer's disease and related dementias. It is designed for researchers and institutions engaged in innovative studies that can lead to new therapeutic strategies. The funding supports projects that utilize bioinformatics tools and experimental methodologies to explore drug repositioning and combination therapies, ultimately aiming to improve patient outcomes in this critical area of healthcare.
Eligibility
Eligible applicants include academic institutions, nonprofit organizations, and other research entities with a focus on Alzheimer's disease and related dementias.